NYSE:ALUR Allurion Technologies (ALUR) Stock Price, News & Analysis $2.54 -0.24 (-8.63%) Closing price 03:59 PM EasternExtended Trading$2.50 -0.04 (-1.38%) As of 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Allurion Technologies Stock (NYSE:ALUR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Allurion Technologies alerts:Sign Up Key Stats Today's Range$2.35▼$3.0950-Day Range$2.22▼$3.6052-Week Range$2.15▼$88.75Volume1.04 million shsAverage Volume780,346 shsMarket Capitalization$18.94 millionP/E RatioN/ADividend YieldN/APrice Target$22.83Consensus RatingBuy Company OverviewAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Read More… Allurion Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreALUR MarketRank™: Allurion Technologies scored higher than 68% of companies evaluated by MarketBeat, and ranked 325th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAllurion Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAllurion Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Allurion Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Allurion Technologies are expected to grow in the coming year, from ($9.96) to ($7.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Allurion Technologies is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Allurion Technologies is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Allurion Technologies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.23% of the float of Allurion Technologies has been sold short.Short Interest Ratio / Days to CoverAllurion Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Allurion Technologies has recently decreased by 18.72%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAllurion Technologies does not currently pay a dividend.Dividend GrowthAllurion Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.23% of the float of Allurion Technologies has been sold short.Short Interest Ratio / Days to CoverAllurion Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Allurion Technologies has recently decreased by 18.72%, indicating that investor sentiment is improving significantly. News and Social Media2.3 / 5News Sentiment0.17 News SentimentAllurion Technologies has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Allurion Technologies this week, compared to 2 articles on an average week.Search Interest7 people have searched for ALUR on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Allurion Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $26,800.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders22.40% of the stock of Allurion Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.39% of the stock of Allurion Technologies is held by institutions.Read more about Allurion Technologies' insider trading history. Receive ALUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Allurion Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address ALUR Stock News HeadlinesAllurion Shares Jump on Weight-Loss Study ResultsMay 27 at 9:45 PM | marketwatch.comAllurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain ResultsMay 27 at 9:28 PM | insidermonkey.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. May 28, 2025 | Porter & Company (Ad)Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion ProgramMay 27 at 4:05 PM | businesswire.comAllurion Technologies (NYSE:ALUR) Upgraded at Wall Street ZenMay 25 at 3:47 AM | americanbankingnews.comRoth Capital Has Bullish Estimate for ALUR FY2025 EarningsMay 20, 2025 | americanbankingnews.comEarnings call transcript: Allurion Technologies Q1 2025 sees revenue drop, stock surgesMay 16, 2025 | uk.investing.comAllurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call TranscriptMay 15, 2025 | msn.comSee More Headlines ALUR Stock Analysis - Frequently Asked Questions How have ALUR shares performed this year? Allurion Technologies' stock was trading at $10.75 at the beginning of 2025. Since then, ALUR shares have decreased by 76.4% and is now trading at $2.5350. View the best growth stocks for 2025 here. How were Allurion Technologies' earnings last quarter? Allurion Technologies Inc. (NYSE:ALUR) posted its quarterly earnings data on Wednesday, May, 14th. The company reported $0.43 EPS for the quarter, topping analysts' consensus estimates of ($1.53) by $1.96. The business earned $5.58 million during the quarter, compared to analyst estimates of $5.50 million. Read the conference call transcript. When did Allurion Technologies' stock split? Allurion Technologies shares reverse split before market open on Friday, January 3rd 2025. The 1-25 reverse split was announced on Tuesday, December 24th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. Who are Allurion Technologies' major shareholders? Top institutional investors of Allurion Technologies include Unisphere Establishment (0.67%), XTX Topco Ltd (0.27%) and Simplex Trading LLC. View institutional ownership trends. How do I buy shares of Allurion Technologies? Shares of ALUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Allurion Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Allurion Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Nuvation Bio (NUVB), Taiwan Semiconductor Manufacturing (TSM), Advanced Micro Devices (AMD), Amprius Technologies (AMPX) and Applied Digital (APLD). Company Calendar Last Earnings5/14/2025Today5/28/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:ALUR Previous SymbolNYSE:ALUR CIK1964979 Webwww.allurion.com Phone508-647-4000FaxN/AEmployees501Year FoundedN/APrice Target and Rating Average Stock Price Target$22.83 High Stock Price Target$50.00 Low Stock Price Target$2.50 Potential Upside/Downside+818.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($12.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$80.61 million Net Margins-71.24% Pretax Margin-70.14% Return on EquityN/A Return on Assets-56.75% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.09 Sales & Book Value Annual Sales$28.30 million Price / Sales0.65 Cash FlowN/A Price / Cash FlowN/A Book Value($36.95) per share Price / Book-0.07Miscellaneous Outstanding Shares7,458,000Free Float2,011,000Market Cap$18.53 million OptionableOptionable Beta-0.58 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NYSE:ALUR) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.